Advanced Oncotherapy (LON:AVO) issued its quarterly earnings data on Monday. The company reported GBX (9.83) (($0.12)) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of GBX (8.90) (($0.11)) by GBX (0.93) (($0.01)), Bloomberg Earnings reports.
LON:AVO remained flat at $GBX 26 ($0.32) on Wednesday. 345,853 shares of the company’s stock were exchanged, compared to its average volume of 79,755. The firm has a market capitalization of $79.66 million and a P/E ratio of -1.86. The company has a quick ratio of 0.79, a current ratio of 2.16 and a debt-to-equity ratio of 55.71. Advanced Oncotherapy has a 1-year low of GBX 20 ($0.25) and a 1-year high of GBX 44.50 ($0.55). The stock’s 50 day moving average is GBX 26.61 and its two-hundred day moving average is GBX 32.04.
About Advanced Oncotherapy
See Also: What is a management fee?
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.